Mounjaro
Tirzepatide
Tirzepatide for type 2 diabetes with clinical oversight
Prescription medication for adults with type 2 diabetes used in personalized provider-supervised care plans.
Mounjaro® may be prescribed off-label for weight management when clinically appropriate.
About Mounjaro
Mounjaro® is an FDA-approved tirzepatide injection for adults with type 2 diabetes. Some patients may also be evaluated for off-label weight-management use when their clinician determines it is medically appropriate.
Key benefits
- Dual-pathway metabolic support for type 2 diabetes
- May support appetite reduction in supervised weight plans
- Gradual dose titration under physician guidance
- Integrated with lifestyle and nutrition support
Who may qualify
- Type 2 diabetes diagnosis or weight criteria per clinician review
- Comprehensive screening for contraindications
- Off-label weight use only when clinically justified
How treatment works
Secure intake & consult
Complete HIPAA-compliant forms and speak with a licensed provider.
Custom care plan
Your clinician selects dose, schedule, and monitoring intervals.
Pharmacy fulfillment
Prescriptions are filled through licensed pharmacies with delivery options.
Good to know
- Off-label weight use requires ongoing physician supervision.
- GI discomfort may occur during dose increases.
- Results vary based on adherence, metabolism, and medical history.
GLP-1 medications are available by prescription only after a licensed provider determines eligibility. This information is educational and not medical advice.
Common questions
Both contain tirzepatide. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is FDA-approved for weight management. Your clinician recommends the appropriate option.
Follow-up frequency depends on your treatment phase, side effects, and clinician guidance — typically monthly or as directed.
Wegovy
Semaglutide
Prescription weight-loss medication for adults with obesity or excess weight and related health conditions.
Zepbound
Tirzepatide
FDA-approved weight management medication containing tirzepatide for adults with obesity or related health conditions.
Ozempic
Semaglutide
GLP-1 prescription medication FDA-approved for type 2 diabetes and prescribed off-label for weight management.